Commandité

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
Rechercher
Catégories
Lire la suite
Sheeba recalls Salman refusing to hug her in front of Aishwarya
Sheeba Chaddha, who played Aishwarya Rai's cousin in 'Hum Dil De Chuke Sanam,' revealed that...
Par BharatUpdates 0 1
'Hope we meet again': Woakes reveals Pant's heartfelt voice note
England's Chris Woakes and India's Rishabh Pant, both injured during the intense...
Par BharatUpdates 0 22
IND vs ENG | 'Shubman scored the most runs, but...' - Ex-RCB all-rounder
Moeen Ali and Adil Rashid have lauded KL Rahul's batting technique in the recent...
Par BharatUpdates 0 22
Move over Kohli, Dhoni, Rohit! Gill puts captaincy worries to rest
In a thrilling Anderson-Tendulkar Trophy series, India drew 2-2 with England, marking a...
Par BharatUpdates 0 23
UML expresses dissent over Election Commission’s political party self-assessment guideline
KATHMANDU: The ruling CPN-UML has expressed strong disagreement with the Election...
Par HamroGlobal 0 22